SPOP Regulates The Biological Mechanism Of Ovarian Cancer Cells Through The Hh Signaling Pathway

Background: Ovarian cancer is characterized by high metastatic potential and high mortality. More than 80% of primary ovarian malignancies are epithelial ovarian cancers. There is increasing evidence that Speckle-type POZ protein (SPOP) is highly correlated with the development of various types of cancer. However, the effects of SPOP on epithelial ovarian cancer and the associated molecular mechanisms remain unclear. Materials and methods: We compared SPOP expression between epithelial ovarian cancer tissues and normal ovarian tissues by using immunohistochemical staining. To determine the role of SPOP in epithelial ovarian cancer cells, we overexpressed or knocked down SPOP in the epithelial ovarian cancer cell line OVCAR-3 using lentiviral vectors. Results: Our results from the present study indicated that SPOP expression was signi fi cantly downregulated in human epithelial ovarian cancer and was associated with the FIGO stage and the histopathologic grading of the tumor. The overexpression and knockdown experiments revealed that SPOP inhibited proliferation while promoting apoptosis in ovarian cancer cells. Inhibition of SPOP mis-activated the Hedgehog (Hh) signaling pathway, thereby inhibiting apoptosis in ovarian cancer cells. Conclusion: SPOP suppresses proliferation and promotes apoptosis in human ovarian cancer cells by inhibiting the Hh signaling pathway, offering the possibility of new approaches for the treatment of ovarian

[1]  Shenmin Zhang,et al.  Functional roles of Speckle-Type Poz (SPOP) Protein in Genomic stability , 2018, Journal of Cancer.

[2]  P. Horák,et al.  Widespread Expression of Hedgehog Pathway Components in a Large Panel of Human Tumor Cells and Inhibition of Tumor Growth by GANT61: Implications for Cancer Therapy , 2018, International journal of molecular sciences.

[3]  S. Zhang,et al.  Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1/sentrin specific peptidase 7. , 2018, Biochemical and biophysical research communications.

[4]  H. Pei,et al.  SPOP suppresses osteosarcoma invasion via PI3K/AKT/NF-κB signaling pathway. , 2018, European review for medical and pharmacological sciences.

[5]  Wenyi Wei,et al.  Tumor suppressor SPOP ubiquitinates and degrades EglN2 to compromise growth of prostate cancer cells. , 2017, Cancer letters.

[6]  M. Rubin,et al.  SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling. , 2017, Cancer cell.

[7]  X. Zhi,et al.  Silencing speckle-type POZ protein by promoter hypermethylation decreases cell apoptosis through upregulating Hedgehog signaling pathway in colorectal cancer , 2016, Cell Death and Disease.

[8]  Qiubo Yu,et al.  Speckle-type POZ (pox virus and zinc finger protein) protein gene deletion in ovarian cancer: Fluorescence in situ hybridization analysis of a tissue microarray. , 2016, Oncology letters.

[9]  C. Mayr,et al.  Differential role of Hedgehog signaling in human pancreatic (patho-) physiology: An up to date review. , 2016, World journal of gastrointestinal pathophysiology.

[10]  Haixia Li,et al.  Hedgehog signaling pathway as a therapeutic target for ovarian cancer. , 2016, Cancer epidemiology.

[11]  J. Cheville,et al.  Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation. , 2015, Molecular cell.

[12]  Yan Tang,et al.  Tumor suppressor SPOP mediates the proteasomal degradation of progesterone receptors (PRs) in breast cancer cells. , 2015, American journal of cancer research.

[13]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[14]  L. Yu,et al.  Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-α protein turnover , 2015, Cell Death and Disease.

[15]  Tao Liu,et al.  SPOP suppresses tumorigenesis by regulating Hedgehog/Gli2 signaling pathway in gastric cancer , 2014, Journal of experimental & clinical cancer research : CR.

[16]  Kevin P. White,et al.  SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer. , 2014, Cancer cell.

[17]  Qing Zhang,et al.  Hedgehog signaling downregulates Suppressor of Fused through the HIB/SPOP-Crn axis in Drosophila , 2014, Cell Research.

[18]  Long Yu,et al.  Destruction of Full-Length Androgen Receptor by Wild-Type SPOP, but Not Prostate-Cancer-Associated Mutants , 2014, Cell reports.

[19]  I. Sumara,et al.  The emerging family of CULLIN3‐RING ubiquitin ligases (CRL3s): cellular functions and disease implications , 2013, The EMBO journal.

[20]  Qi Chen,et al.  Hedgehog signaling pathway and ovarian cancer. , 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[21]  J. Briscoe,et al.  The mechanisms of Hedgehog signalling and its roles in development and disease , 2013, Nature Reviews Molecular Cell Biology.

[22]  M. Rubin,et al.  Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover , 2013, Proceedings of the National Academy of Sciences.

[23]  A. Gerger,et al.  Hedgehog Signaling Pathway in Ovarian Cancer , 2013, International journal of molecular sciences.

[24]  Nancy F. Hansen,et al.  Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes , 2012, Nature Genetics.

[25]  A. Sivachenko,et al.  Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer , 2012, Nature Genetics.

[26]  B. O’Malley,et al.  Tumor Suppressor Role for the SPOP Ubiquitin Ligase in Signal-Dependent Proteolysis of the Oncogenic Coactivator SRC-3/AIB1 , 2011, Oncogene.

[27]  R. Toftgård,et al.  Hedgehog beyond medulloblastoma and basal cell carcinoma. , 2010, Biochimica et biophysica acta.

[28]  B. Wang,et al.  Multiple Ser/Thr-rich degrons mediate the degradation of Ci/Gli by the Cul3-HIB/SPOP E3 ubiquitin ligase , 2009, Proceedings of the National Academy of Sciences.

[29]  J Wade Harper,et al.  Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases. , 2009, Molecular cell.

[30]  F. D. de Sauvage,et al.  Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. , 2009, Trends in pharmacological sciences.

[31]  P. Ip,et al.  Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation , 2008, Carcinogenesis.

[32]  C. Chien,et al.  A hedgehog-induced BTB protein modulates hedgehog signaling by degrading Ci/Gli transcription factor. , 2006, Developmental cell.

[33]  P. Ingham,et al.  Hedgehog signaling in animal development: paradigms and principles. , 2001, Genes & development.

[34]  Tao Song,et al.  Decreased expression of the SPOP gene is associated with poor prognosis in glioma. , 2015, International journal of oncology.

[35]  Gong Yang,et al.  Ovarian cancer: pathology, biology, and disease models. , 2009, Frontiers in bioscience.

[36]  A. Cheung,et al.  Aberrant activation of hedgehog signaling pathway in ovarian cancers: Effect on prognosis, cell invasion and differentiation , 2008 .